Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Some women with common hair loss may develop permanent hair loss.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

LED therapy is safe and shows potential for treating skin conditions and promoting hair growth, but more research is needed.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Different hair loss types need accurate diagnosis for proper treatment.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.